Understanding OTC Personal Care Packaging Requirements

If your personal care brand includes a product that treats, prevents, or relieves a health condition, it is most likely regulated as an over-the-counter drug rather than a cosmetic. That distinction changes everything about how the product is packaged, labeled, and manufactured. Understanding what goes into OTC personal care packaging compliance before you approach a co-packer can save your brand from costly setbacks down the road.

Closeup of various over-the-counter pharmaceutical products

What Sets OTC Products Apart

The line between cosmetics and OTC drugs is easy to blur, especially in the personal care sector. Products like acne treatments, antiperspirants, anti-dandruff shampoos, and medicated lip balms are all classified as over-the-counter drugs because they are intended to affect the structure or function of the body. That classification means they are subject to FDA drug regulations under 21 CFR, not simply the cosmetic guidelines many brands are already familiar with.

Before OTC personal care packaging ever reaches a consumer, it must meet a separate and more rigorous set of federal standards governing everything from label content to how the product is manufactured and documented.

OTC products carry a heavier regulatory burden because their intended use creates a real risk of consumer harm if standards are not followed. A shampoo that claims to treat dandruff is not just a beauty product in the eyes of the FDA. It is a drug, and it will be held to drug-level packaging and labeling standards accordingly.

Drug Facts Labeling Requirements

One of the most recognizable elements of OTC personal care packaging is the Drug Facts panel. Unlike the standard ingredient list found on cosmetic packaging, the Drug Facts panel follows a very specific format required by 21 CFR Part 201 and must include designated sections in a prescribed order. Getting this right is one of the most critical steps in OTC labeling compliance, and brands that underestimate it often face misbranding citations before their product ever hits a shelf.

What the Drug Facts Panel Must Include

The Drug Facts label is not simply a list of ingredients. It is a standardized information block that must contain all of the following, presented in a specific sequence:

Active ingredients and their stated purposes
Uses, including the specific conditions the product is intended to treat or relieve
Warnings, such as allergy information, drug interactions, and usage restrictions for certain populations
Directions for safe use, including dosage frequency and method of administration
Inactive ingredients that may affect individuals with sensitivities
Other information such as storage recommendations and expiration guidance

These elements must follow strict formatting rules including a minimum type size of six-point font, bold headings, and clearly delineated sections. These are not optional style preferences. They are enforceable FDA requirements, and a product that does not comply can be declared misbranded and pulled from distribution.

Label Size and Space Constraints

Many personal care brands underestimate how much real estate the Drug Facts panel requires, particularly on smaller packaging formats like tubes, travel-size bottles, and single-dose packets. When the full label content cannot fit legibly, manufacturers can use expanded content labels or peel-back constructions to accommodate all required information without crowding. Planning for this early in the packaging design process prevents costly delays during production runs.

Tamper-Evident and Child-Resistant Packaging

Two of the most important structural requirements in OTC personal care packaging are tamper-evident packaging and child-resistant packaging. Both are legally required under separate federal regulations, and both must be addressed before a product can be sold at retail.

Tamper-Evident Packaging Under 21 CFR 211.132

Under 21 CFR 211.132, most OTC drug products must be packaged in tamper-evident packaging. This means the package must have at least one indicator or barrier that provides visible evidence to consumers if tampering has occurred. The tamper-evident feature must also be distinctive by design, meaning it cannot be easily duplicated with common materials or replicated without leaving clear evidence of entry.

Child-Resistant Packaging Under 16 CFR Part 1700

Child resistant packaging requirements are governed separately under the Poison Prevention Packaging Act and enforced by the Consumer Product Safety Commission under 16 CFR Part 1700. Certain OTC drug categories, including products containing acetaminophen, ibuprofen, and aspirin, require packaging that a child under five years old cannot easily open. If your product contains any of these active ingredients, child resistant packaging is a non-negotiable compliance requirement, not an optional upgrade.

Fill Accuracy and Batch Documentation

Beyond labels and closures, OTC personal care packaging compliance extends into the manufacturing process itself. Fill accuracy requirements ensure that the net quantity declared on the label matches what is actually in the package. Under the Fair Packaging and Labeling Act, net quantity statements must accurately reflect contents, and co-packers operating under cGMP requirements are expected to maintain fill accuracy controls and records throughout every production run.

Batch documentation is equally critical. Every production run must be fully traceable, and a qualified co-packer should be capturing all of the following for each batch:

Raw material inputs, including lot numbers and supplier information
Fill weights and net quantity verification data
Equipment used and calibration status at the time of production
Any deviations that occurred during packaging and how they were resolved
Finished product inspection results before release

This documentation supports both regulatory inspections and recall readiness. When selecting a co-packer for OTC personal care packaging, confirming that they maintain thorough batch records at every stage is a fundamental compliance requirement, not just a best practice.

Explore how ChemRite CoPac’s regulated co-packing solutions are built to meet the full scope of OTC personal care packaging requirements, from label to closure to batch record.

Our Packing Solutions

Stability Testing in OTC Manufacturing

Stability testing is a requirement that surprises many emerging brands entering the OTC personal care space. Because these products are classified as drugs, they must demonstrate that the formulation remains safe, effective, and within specification throughout its stated shelf life. This means testing the product and its packaging under both accelerated and real-time conditions to confirm that neither degrades in a way that compromises the product’s intended use or consumer safety.

Stability data also supports the expiration date printed on the packaging. Without it, a brand cannot legitimately claim a shelf life, and a co-packer operating under cGMP requirements will not initiate production without this documentation already in place.

cGMP Requirements and the Role of the Co-Packer

All OTC drug manufacturing in the United States must conform to current Good Manufacturing Practices, known as cGMPs, as required under Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act. These standards govern how a product is manufactured, processed, and packaged, and they apply whether that work is being done by the brand’s own facility or a contracted co-packer.

What cGMP Means for Packaging Operations

When a co-packer handles OTC personal care packaging under cGMP requirements, every step of the packaging operation is subject to quality controls, documentation requirements, and inspection-readiness standards. Any co-packer handling regulated personal care manufacturing should be able to demonstrate compliance across all of the following areas:

Equipment maintenance, calibration, and documentation for all production machinery
Facility design that actively prevents contamination and cross-contamination between product runs
Documented standard operating procedures for every critical process in the packaging operation
Personnel training records demonstrating that all operators follow validated procedures
A deviation management system that captures, investigates, and corrects any departure from established standards

If an FDA inspector visits the facility, the co-packer must be able to produce written evidence for each of these areas on demand. A facility that meets cosmetic or food-grade standards but not drug-level cGMP expectations is not a suitable partner for OTC production.

Partnering With a Co-Packer Who Knows the Rules

OTC personal care packaging is a discipline that goes well beyond printing a Drug Facts panel and sealing a bottle. From tamper-evident closures and child-resistant caps to stability-backed expiration dates and batch-level traceability, every element of the packaging process is governed by federal regulations that carry real consequences when overlooked.

For personal care brands entering the OTC space, choosing the right co-packing partner is one of the most important decisions you will make. ChemRite CoPac brings regulated manufacturing expertise to every project, combining cGMP-compliant operations with the hands-on guidance needed to navigate OTC personal care packaging from concept through compliance. When the regulatory stakes are high, working with a co-packer who already knows the requirements is the clearest path to a successful and defensible product launch.